Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations
- PMID: 34023340
- DOI: 10.1016/j.diabres.2021.108867
Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations
Abstract
Aims: Maturity-Onset Diabetes of the Young (MODY) caused by glucokinase (GCK) mutations is characterized by lifelong mild non-progressive hyperglycemia, with low frequency of coronary artery disease (CAD) compared to other types of diabetes. The aim of this study is to estimate cardiovascular risk by coronary artery calcification (CAC) score in this group.
Materials and methods: Twenty-nine GCK-MODY cases, 26 normoglycemic controls (recruited among non-affected relatives/spouses of GCK mutation carriers), and 24 unrelated individuals with type 2 diabetes were studied. Patients underwent CAC score evaluation by computed tomography and were classified by Agatston score ≥ or < 10. Framingham Risk scores of CAD in 10 years were calculated.
Results: Median [interquartile range] CAC score in GCK-MODY was 0 [0,0], similar to controls (0 [0,0], P = 0.49), but lower than type 2 diabetes (39 [0, 126], P = 2.6 × 10-5). A CAC score ≥ 10 was seen in 6.9% of the GCK group, 7.7% of Controls (P = 1.0), and 54.2% of individuals with type 2 diabetes (P = 0.0006). Median Framingham risk score was lower in GCK than type 2 diabetes (3% vs. 13%, P = 4 × 10-6), but similar to controls (3% vs. 4%, P = 0.66).
Conclusions: CAC score in GCK-MODY is similar to control individuals from the same family and/or household and is significantly lower than type 2 diabetes. Besides demonstrating low risk of CAD in GCK-MODY, these findings may contribute to understanding the specific effect of hyperglycemia in CAD.
Keywords: Coronary artery calcium; Coronary artery disease; Glucokinase; MODY; Monogenic diabetes.
Copyright © 2021 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).BMC Pediatr. 2018 Mar 6;18(1):101. doi: 10.1186/s12887-018-1060-8. BMC Pediatr. 2018. PMID: 29510678 Free PMC article.
-
Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.Diabetes Care. 2015 Jul;38(7):1383-92. doi: 10.2337/dc14-2769. Diabetes Care. 2015. PMID: 26106223 Review.
-
Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.Curr Diabetes Rev. 2022;18(6):e060821195358. doi: 10.2174/1573399817666210806110633. Curr Diabetes Rev. 2022. PMID: 34365926
-
Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.Endocr J. 2022 Apr 28;69(4):473-477. doi: 10.1507/endocrj.EJ21-0526. Epub 2021 Nov 19. Endocr J. 2022. PMID: 34803122
-
Clinical implications of the glucokinase impaired function - GCK MODY today.Physiol Res. 2020 Dec 22;69(6):995-1011. doi: 10.33549/physiolres.934487. Epub 2020 Nov 2. Physiol Res. 2020. PMID: 33129248 Free PMC article. Review.
Cited by
-
NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report.BMC Endocr Disord. 2021 Oct 15;21(1):202. doi: 10.1186/s12902-021-00864-w. BMC Endocr Disord. 2021. PMID: 34654408 Free PMC article.
-
Granuloma annulare and necrobiosis lipoidica in a patient with HNF1A-MODY.Arch Endocrinol Metab. 2022 May 13;66(3):420-424. doi: 10.20945/2359-3997000000477. Epub 2022 May 12. Arch Endocrinol Metab. 2022. PMID: 35551682 Free PMC article.
-
Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.J Diabetes. 2023 Jun;15(6):519-531. doi: 10.1111/1753-0407.13390. Epub 2023 May 24. J Diabetes. 2023. PMID: 37226652 Free PMC article.
-
Pancreatic beta-cell function dynamics in youth with GCK, HNF1A, and KCNJ11 genes mutations during mixed meal tolerance test.Pediatr Diabetes. 2022 Nov;23(7):1009-1016. doi: 10.1111/pedi.13404. Epub 2022 Sep 6. Pediatr Diabetes. 2022. PMID: 36068963 Free PMC article.
-
Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG).Arch Endocrinol Metab. 2024 Jul 30;68:e230314. doi: 10.20945/2359-4292-2023-0314. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39420902 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous